It also reduces the expression of DN markers such as CTGF, TGF-β1, fibronectin, collagen IV, RhoA, IL-1β, ROCK2, and p-MYPT1 in DN kidney tissues. The gene discussed is FN1; the disease is liver dysplastic nodule.